Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 6/20 | 0.67 |
| ▸ | AKR1B10 | O60218 | 4/20 | 0.61 |
| ▸ | AKR1B1 | P15121 | 4/20 | 0.61 |
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.59 |
| ▸ | EGFR | P00533 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 2/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | MAOB | P27338 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Heptyl Cinnamate SCHEMBL2290288 | 1.00 | APP (0.67) | APPAKR1B10AKR1B1HCAR2EGFR | |
| SCHEMBL3683468 | 1.00 | APP (0.67) | APPAKR1B10AKR1B1HCAR2EGFR | |
| Heptyl Cinnamate SCHEMBL2290285 | 1.00 | APP (0.67) | APPAKR1B10AKR1B1HCAR2EGFR | |
| SCHEMBL32075 | 1.00 | APP (0.67) | APPAKR1B10AKR1B1HCAR2EGFR | |
| SCHEMBL1170007 | 1.00 | APP (0.67) | APPAKR1B10AKR1B1HCAR2EGFR | |
| SCHEMBL13478962 | 1.00 | APP (0.67) | APPAKR1B10AKR1B1HCAR2EGFR | |
| SCHEMBL19460592 | 1.00 | APP (0.67) | APPAKR1B10AKR1B1HCAR2EGFR | |
| Octyl Cinnamate SCHEMBL157363 | 1.00 | APP (0.67) | APPAKR1B10AKR1B1HCAR2EGFR | |
| SCHEMBL1170009 | 1.00 | APP (0.67) | APPAKR1B10AKR1B1HCAR2EGFR | |
| SCHEMBL19460590 | 1.00 | APP (0.67) | APPAKR1B10AKR1B1HCAR2EGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1229 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110869850-B | Flexographic printing plate with improved storage stability | 麦克德米德图像方案股份有限公司 | 2023-07-21 | — | — | CN | claimed |
| CN-107213027-B | Cosmetic composition with skin repairing and moistening functions and preparation method thereof | 广州澳希亚实业有限公司 | 2020-06-26 | — | — | CN | claimed |
| US-20190299032-A1 | Oil-In-Water Type Emulsion Cosmetic Composition | SHISEIDO COMPANY, LTD. (JP) | 2019-10-03 | — | — | US | claimed |
| US-20180056096-A1 | Oil-In-Water Type Emulsion Cosmetic Composition | SHISEIDO CO., LTD. (JP) | 2018-03-01 | — | — | US | claimed |
| US-20160128944-A1 | COATED PARTICLES AND COMPOSITIONS COMPRISING SAME | VYOME THERAPEUTICS LIMITED (IN) | 2016-05-12 | — | — | US | claimed |
| EP-3003031-A1 | COATED PARTICLES AND COMPOSITIONS COMPRISING SAME | Vyome Biosciences Pvt Ltd (IN) | 2016-04-13 | — | — | EP | claimed |
| WO-2014195872-A1 | COATED PARTICLES AND COMPOSITIONS COMPRISING SAME | VYOME BIOSCIENCES PVT. LTD. (IN) | 2014-12-11 | — | — | WO | claimed |
| US-8404258-B2 | External preparation for the skin | SHISEIDO COMPANY, LTD. (JP) | 2013-03-26 | — | — | US | claimed |
| US-20100221315-A1 | VESICULAR FORMULATIONS CONTAINING ORGANIC ACID PRODRUGS, PROCESS FOR THEIR PREPARATION | UNIVERSIDADE DE LISBOA (PT) | 2010-09-02 | — | — | US | claimed |
| US-7741508-B2 | Single step green process for the preparation of substituted cinnamic esters with trans-selectivity | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2010-06-22 | — | — | US | claimed |
| US-20100047185-A1 | ACTVIE SUBSTANCE COMBINATION | ISDIN S.A. (ES) | 2010-02-25 | — | — | US | claimed |
| EP-2034962-A2 | VESICULAR FORMULATIONS CONTAINING ORGANIC ACID PRODRUGS AND PROCESS FOR THEIR PREPARATION. | Universidade de Lisboa (PT) | 2009-03-18 | — | — | EP | claimed |
| EP-2018403-A1 | WATER DISPERSIBLE FILMS FOR DELIVERY OF ACTIVE AGENTS TO THE EPIDERMIS | Eastman Chemical Company (US) | 2009-01-28 | — | — | EP | claimed |
| WO-2008083974-A1 | ACTIVE SUBSTANCE COMBINATION | ISDIN S.A. (ES) | 2008-07-17 | — | — | WO | claimed |
| WO-2008067928-A1 | UV ABSORBING COMPOSITIONS CONTAINING A PYRROLYLTRIAZINE | ISDIN S.A. (ES) | 2008-06-12 | — | — | WO | claimed |
| US-20080045742-A1 | Single step green process for the preparation of substituted cinnamic esters with trans-selectivity | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2008-02-21 | — | — | US | claimed |
| WO-2007142548-A2 | VESICULAR FORMULATIONS CONTAINING ORGANIC ACID PRODRUGS, PROCESS FOR THEIR PREPARATION | UNIVERSIDADE DE LISBOA (PT) | 2007-12-13 | — | — | WO | claimed |
| WO-2007133508-A1 | WATER DISPERSIBLE FILMS FOR DELIVERY OF ACTIVE AGENTS TO THE EPIDERMIS | EASTMAN CHEMICAL COMPANY (US) | 2007-11-22 | — | — | WO | claimed |
| US-20070258935-A1 | Water dispersible films for delivery of active agents to the epidermis | EASTMAN CHEMICAL COMPANY | 2007-11-08 | — | — | US | claimed |
| US-20030003069-A1 | Multiple phase foaming personal cleansing products | ALZO INTERNATIONAL, INC. | 2003-01-02 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190299032-A1 | Oil-In-Water Type Emulsion Cosmetic Composition | CD44, DSG1, CUTA | APP 1323/4885AKR1B10 2245/4885AKR1B1 3545/4885 |
| US-20100047185-A1 | ACTVIE SUBSTANCE COMBINATION | UGT2B17, TACR2, UGT1A1 | APP 809/4885AKR1B10 277/4885AKR1B1 310/4885 |
| US-20080045742-A1 | Single step green process for the preparation of substituted cinnamic esters with trans-selectivity | ADH5, CYP2E1, ADH1A | APP 1560/4885AKR1B10 609/4885AKR1B1 426/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.